Discounted IVF drugs now available via TrumpRx website

US President Donald Trump's anticipated drug-discount programme TrumpRx is now live, and offers price reductions on a range of prescription medications, including some widely-used IVF drugs.

The website launched on 5 February, and aims to address the high costs of medication in the USA, offering discounts on 43 drugs, including those for weight loss, diabetes, menopause and fertility treatment. Although TrumpRx does not sell medicines directly, it directs consumers to purchase discounted prescription drugs straight from manufacturers and offers digital coupons, redeemable at participating pharmacies. Four IVF medications are listed on the site, and the Centres for Medicare and Medical Services estimates that fertility patients could save up to $2200 per cycle.

'For very niche populations and very specific medication, at least in the case of infertility, it looks like this might be a good deal,' Dr Rena Conti, associate professor of markets, public policy, and law at Boston University's Questrom School of Business, told the Guardian. 'This is not fundamentally altering access or furthering transparency at this point in time, except for a very few selected patients who are using a very limited set of drugs'.

Among the fertility medications available via TrumpRX is Gonal F, a fertility medication commonly used to help stimulate ovulation. It is available for $168 on TrumpRx compared with $432 via Alto Pharmacy, according to GoodRx, a healthcare provider which offers similar discount services.

The inclusion of IVF medications follows President Trump's pledge to make IVF more widely accessible, announced in his executive order in 2025 (see BioNews 1278) and earlier election campaign (see BioNews 1258). However, the extent of that accessibility has come under renewed scrutiny since TrumpRx went live, as medication represents only a small fraction of total IVF treatment costs. A single cycle can cost as much as $30,000 and fertility treatment is often not covered by medical insurance.

'We are pleased to see fertility medications included in the TrumpRx portal. There is no question that lower drug costs will be helpful for patients navigating fertility treatment... There are, however, plenty of questions as to just how helpful this program will be,' said Sean Tipton, chief advocacy and policy officer, American Society for Reproductive Medicine (ASRM). 'This move alone does not make IVF attainable for most patients.'

He added: 'ASRM urges President Trump and Congress to move beyond incremental steps and focus on solutions that truly make fertility care accessible and affordable for all patients who need it.'

While the TrumpRx site may offer savings for people purchasing fertility and weight-loss medications, often not covered by insurance, the benefits beyond this are less clear. Nearly half of the 43 brand-name medicines on the site have lower-priced generics available elsewhere, and the site itself does not flag when such alternatives exist. Therefore, some patients could still find better deals through established routes such as insurance, retail pharmacies, or existing discount platforms.

The White House has said that more medications will be added to the platform in the coming months.